A wonderful article from PWN contributor Linda M. Rio on the far-reaching effects of pituitary disorders was recently published by the Pacific Neuroscience Institute. Read the article here. Read more articles on the connection between pituitary disease
There is quite a bit of noise out there about Gene Therapy. What it is, how it works, what can it actually do? Some of the information is very good, some, not so good.
A recent New York Times Sunday Magazine article by Lisa Sanders M.D. featured PWN cofounder Lewis Blevins, M.D. and the experiences of one of his patients with an acromegaly diagnosis. The article “The Patient Had
From Jill Sisco, patient advocate, president of the acromegaly community and PWN contributor comes this commentary on insurance out-of-pocket charges and an update on acromegaly clinical trials. As a patient leader, that runs a
From our friends at the Pacific Neuroscience Institute, a captivating discussion by Dr. Daniel F. Kelly, neurosurgeon, director, and founder at Pacific Neuroscience Institute.
From the desk of Linda M. Rio, M.A., Marriage and Family Therapist and PWN contributor. I recently met with someone diagnosed with a pituitary tumor who inspired me to write about this topic. I realize
Listen to a discussion of Acromegaly cases that, for a variety of clinical and biochemical reasons, are difficult to discern. Learn about people with definite acromegaly but negative MRI studies. Why are some microadenomas
From Linda M. Rio, Marriage and Family Therapist – So, what is the tipping point where the word “pituitary” will no longer have to be spelled-out and described in its most basic form? I just
In a fantastic photo exposition from our friends at the Spanish Acromegaly Association, Raquel Ciriza, and her team illustrate this point with stunning, beautiful visuals of people with Acromegaly. We don’t have to portrait Bond Villains,
Each year, the University of California, San Francisco graduates four neurosurgical residents who have met the basic qualifications to become practicing neurosurgeons. Most, however, go on to additional training to subspecialize in the field of
Today the National Organization for Rare Disorders – NORD – issued a statement and provided a very useful explanation regarding the increasing use of copay accumulator programs in health plans. The NORD statement reads in part: “Recently,
Español From the desk of Jorge D Faccinetti Cofounder and Chairman, Pituitary World News – I recently learned that substandard drugs for acromegaly and other pituitary disorders are alleged to be making their way